Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Seton Hall Law School to Host ‘Managing Counterfeiting Issues In The Pharmaceutical Industry’ June 18

Newark, NJ, June 12, 2013 — The Gibbons Institute of Law, Science & Technology at Seton Hall Law School will present “Managing Counterfeiting Issues in the Pharmaceutical Industry” on Tuesday, June 18 at Seton Hall Laws School in Newark from 5 p.m. to 7 p.m.

Pharmaceutical counterfeiting poses a deadly threat to consumers and harms both the reputation and financial condition of pharmaceutical companies. 

Pharmaceutical companies are not the only ones facing this growing concern.  Pharmacies, hospitals, doctors, insurance companies, and others who are involved in marketing, distributing or purchasing pharmaceutical and medical device products are at risk.  Just one batch of counterfeit drugs could not only affect your reputation but could close down your company.

The law school’s program will identify practical, anti-counterfeiting strategies and discuss how drug companies can develop and implement tailored “best practices” to deter and combat counterfeiters.

This CLE program will feature industry leaders who will provide an overview of the counterfeit drug problem and discuss strategies to combat counterfeiters in the United States and worldwide.

Topics of discussion will include:

  • The use of technology in inventory tracking and product authentication
  • Employee training programs
  • The development of comprehensive investigative and enforcement strategies.

Panelists scheduled to participate are:

  • Catherine A. Begley, Regional Security Director for the North America Region, Merck
  • Kathleen H. Dooley, Partner, McGuireWoods LLP 
  • Owen J. McKeon, Director, Intellectual Property Department, Gibbons P.C.
  • David W. Opderbeck, Professor of Law and Director, Gibbons Institute of Law, Science & Technology
  • Estelle J. Tsevdos, Ph.D., Director, Intellectual Property Department, Gibbons P.C.

For information or to register, click here or contact Teresa Rizzo at teresa.rizzo@shu.edu.